Bortezomib Completed Phase 2 Trials for Duct Cell Adenocarcinoma of the Pancreas / Stage IV Pancreatic Cancer Treatment

IndicationsStatusPurposePhase
CompletedTreatment2
clinicaltrials.gov IdentifierTitleDrugs
NCT00052689Bortezomib With or Without Gemcitabine in Treating Patients With Metastatic Pancreatic Cancer